0 Ratings
ID

22458

Description

Study part: Status of treatment blind.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

Versions (1)
  1. 6/5/17 6/5/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

June 5, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Status of treatment blind Mepolizumab HES NCT00086658

    English

    Status of treatment blind

    1 forms  
    STATUS OF TREATMENT BLIND
    Description

    STATUS OF TREATMENT BLIND

    Alias
    UMLS CUI-1
    C0749659 (Treatment Status)
    UMLS CUI-2
    C2347038 (Blinded Clinical Study)
    Study ID
    Description

    Study ID

    Data type

    text

    Alias
    UMLS CUI [1]
    C2826693 (Study Identifier)
    Was the treatment blind broken during the study?
    Description

    Status of treatment blind

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0749659 (Treatment Status)
    UMLS CUI [1,2]
    C2347038 (Blinded Clinical Study)
    Date blind broken
    Description

    date Blinded Clinical Study

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0011008 (Date in time)
    SNOMED
    410671006
    UMLS CUI [1,2]
    C2347038 (Blinded Clinical Study)
    Reason blind broken
    Description

    Complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product pages, as appropriate.

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0392360 (Indication of (contextual qualifier))
    SNOMED
    230165009
    LOINC
    MTHU008319
    UMLS CUI [1,2]
    C2347038 (Blinded Clinical Study)
    If other, please specify
    Description

    Other

    Data type

    text

    Alias
    UMLS CUI [1]
    C0205394 (Other)
    SNOMED
    74964007
    LOINC
    LP21049-9
    Back to the top of the page

    Similar models

    Status of treatment blind

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    STATUS OF TREATMENT BLIND
    C0749659 (UMLS CUI-1)
    C2347038 (UMLS CUI-2)
    Study ID
    Item
    Study ID
    text
    C2826693 (UMLS CUI [1])
    Status of treatment blind
    Item
    Was the treatment blind broken during the study?
    boolean
    C0749659 (UMLS CUI [1,1])
    C2347038 (UMLS CUI [1,2])
    date Blinded Clinical Study
    Item
    Date blind broken
    date
    C0011008 (UMLS CUI [1,1])
    C2347038 (UMLS CUI [1,2])
    Item
    Reason blind broken
    text
    C0392360 (UMLS CUI [1,1])
    C2347038 (UMLS CUI [1,2])
    Reason
    Code List
    Reason blind broken
    CL Item
    Medical emergency requiring identification of investigational product for further treatment (Medical emergency requiring identification of investigational product for further treatment)
    CL Item
    Other, specify (Other, specify)
    Other
    Item
    If other, please specify
    text
    C0205394 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial